Format

Send to

Choose Destination
Heart Lung Circ. 2014 Oct;23(10):e198-201. doi: 10.1016/j.hlc.2014.04.006. Epub 2014 Apr 18.

Prognostic coronary surgery in a case of malignant mesothelioma previously managed with trimodality treatment.

Author information

1
Department of Cardiothoracic Surgery, Strathfield Private Hospital, Sydney, Australia; Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia; The Baird Institute, Sydney, Australia; Department of Surgery, Sydney Medical School, The University of Sydney, Sydney, Australia. Electronic address: vikrantdhurandhar@hotmail.com.
2
Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia; The Baird Institute, Sydney, Australia.
3
Department of Cardiothoracic Surgery, Strathfield Private Hospital, Sydney, Australia; Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia; The Baird Institute, Sydney, Australia; Department of Surgery, Sydney Medical School, The University of Sydney, Sydney, Australia.
4
Healthscope Pathology, Sydney, Australia.

Abstract

We report a case of malignant pleural mesothelioma treated with trimodality treatment. At three years after the extrapleural pneumonectomy, coronary artery revascularisation surgery for NSTEMI was performed in view of favourable long term prognostic and survival outcome. Five years following pleuropneumonectomy there is no clinical or radiological evidence of mesothelioma and the patient remains free of cardiac symptoms.

KEYWORDS:

CABG; Mesothelioma; Pleura; Pneumonectomy; Trimodality therapy

PMID:
24996387
DOI:
10.1016/j.hlc.2014.04.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center